fda glp-1 compounding warning letters september 2025 Democratic lawmakers are pressing the Trump administration to FDA restricts non-approved compounded GLP-1

IGF-1 is mitogenic: it promotes cell growth and inhibits apoptosis, and epidemiological studies have linked chronically elevated IGF-1 to increased risk of several cancers, most consistently colorectal, breast, and prostate

In cartilage research, a 2015 study in a collagenase-induced knee osteoarthritis rabbit model showed that combined AOD-9604 and hyaluronic acid injections were significantly more effective than either treatment alone, with treated groups showing lower gross morphological and histopathological scores

& Bornfeldt, K

In essence, the FDA regulates a wide range of products to ensure they are safe and effective for their intended use

However, Swiss Chems received an FDA warning letter in December 2024 regarding product labeling and marketing practices, and their checkout adds a 5% processing fee on card transactions alongside KYC (know-your-customer) identity verification requirements